Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases

Details for Australian Patent Application No. 2007309229 (hide)

Owner GENENTECH, INC.

Inventors Wu, Wenjuan; Singh, Sanjaya; Li, Kang; Zhou, Bin-Bing Stephen; Fung, Sek Chung

Agent Griffith Hack

Pub. Number AU-A-2007309229

PCT Pub. Number WO2008/051797

Priority 60/879,218 06.01.07 US; 60/852,861 19.10.06 US

Filing date 18 October 2007

Wipo publication date 2 May 2008

International Classifications

C07K 14/43 (2006.01) Peptides having more than 20 amino acids

A61K 31/717 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051797 Priority application(s): WO2008/051797

28 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Apr 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309232-Visual prosthesis

2007309227-Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative